Inhibition of the YAP–TEAD interaction using verteporfin results in decreased EGFR expression and enhanced chemosensitivity to 5-fluorouracil and EGFR inhibitors in mouse xenografts of esophageal cancer (209). Here, EGFR is linked to esophageal cancer.